METFORMIN HYDROCHLORIDE
METFORMIN HYDROCHLORIDE is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: METFORMIN HYDROCHLORIDE; Generic name: METFORMIN HYDROCHLORIDE; Manufacturer: Solco Healthcare US, LLC..
| Brand name | METFORMIN HYDROCHLORIDE |
|---|---|
| Generic name | METFORMIN HYDROCHLORIDE |
| Manufacturer | Solco Healthcare US, LLC. |
| Used for | 1 INDICATIONS AND USAGE Metformin hydrochloride extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Metformin hydrochloride extended-release tablets are a biguanide indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1 ) |
| Dosage | 2 DOSAGE AND ADMINISTRATION • Starting dose: 500 mg orally once daily with the evening meal ( 2.1 ) • Increase the dose in increments of 500 mg every 1 to 2 weeks, up to a maximum of 2,000 mg once daily with the evening meal. ( 2.1 ) • Patients receiving metformin hydrochloride (HCl) tablets may be switched to metformin hydrochloride extended-release tablets once daily at the same total daily dose, up to 2,000 mg once daily. ( 2.1 ) • Swallow metformin hydrochloride extended-release tablets whol |
| Warnings | WARNING: LACTIC ACIDOSIS Postmarketing cases of metformin-associated lactic acidosis have resulted in death, hypothermia, hypotension, and resistant bradyarrhythmias. The onset of metformin-associated lactic acidosis is often subtle, accompanied only by nonspecific symptoms such as malaise, myalgias, respiratory distress, somnolence, and abdominal pain. Metformin-associated lactic acidosis was characterized by elevated blood lactate levels (>5 mmol/Liter), anion gap acidosis (without evidence of |
| Active ingredient(s) | METFORMIN HYDROCHLORIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1016cad7-2198-483c-893b-e25fd397a226 |